Publications by authors named "Mazzitelli Maria"

Almost 25 years have now passed since the first identification of (). It can cause infections both in immunocompetent and immunocompromised hosts. However, it has been rarely described as an aetiology of infectious endocarditis.

View Article and Find Full Text PDF

Objective: Sleep disorders (SD) are prevalent in people with HIV (PWH), but poorly addressed in HIV care. We evaluated the effectiveness of a multidimensional program for SD in an outpatient HIV clinic.

Methods: Interventional study in 175 PWH on ART suffering from insomnia.

View Article and Find Full Text PDF

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, responsible for Coronavirus Disease 2019 (COVID-19), exhibits a spectrum of clinical manifestations, ranging from asymptomatic to severe pulmonary dysfunction or death. The variability in COVID-19 severity has largely been attributed to the host's genetic characteristics, suggesting a polygenic genetic architecture, without significant strong evidence of sex-related genetic differences. In this Italian retrospective case-control study, we investigated the association between COVID-19 severity (severe vs.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic posed significant challenges worldwide, with SARS-CoV-2 vaccines critical in reducing morbidity and mortality. This study evaluates the immunogenicity and antibody persistence of the BNT162b2 vaccine in people living with HIV (PLWH).

Methods: We monitored anti-SARS-CoV-2 Spike IgG concentration in a cohort of PLWH at five time points (T0-T4) using chemiluminescent microparticle immunoassays (CMIAs) at the baselined both during and after vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • - The study explored the effectiveness of early combination treatment (an antiviral plus a monoclonal antibody) versus monotherapy in severely immunocompromised patients with COVID-19.
  • - After evaluating 81 patients, the combination therapy did not significantly reduce mortality or hospitalization rates compared to monotherapy, but it did improve emergency department access.
  • - The findings suggest that early combination therapy may have a positive impact on overall clinical outcomes; however, more research is required to confirm these results.
View Article and Find Full Text PDF

Background: Kaposi Sarcoma (KS) has been historically associated with HIV, especially in people with advanced immunosuppression. Its prevalence decreased over time, but management remains difficult especially when the diagnosis is late and there is a visceral involvement. Bone localization, and particularly the vertebral one, is rare.

View Article and Find Full Text PDF

Background: The introduction of rapid antigen tests revolutionized the approach to SARS-CoV-2 diagnosis, offering prompt and accurate results with high sensitivity and specificity. Although it is more cost- and time-saving than the gold standard, real-time polymerase chain reaction (RT-PCR), the efficacy in general population screening in both hospital- and community-based settings remains unknown. Moreover, rapid antigen testing is limited by qualitative results.

View Article and Find Full Text PDF

Objectives: To evaluate polypharmacy, anticholinergic burden (ACB) and drug-drug interactions (DDIs) in people with four-class-resistant HIV (4DR-PWH).

Methods: We performed a cross-sectional study, including 4DR-PWH from the PRESTIGIO Registry taking at least one non-antiretroviral drug. Polypharmacy was defined as taking five or more non-antiretroviral drugs.

View Article and Find Full Text PDF
Article Synopsis
  • - Cefiderocol, a new antibiotic, is effective against carbapenem-resistant Gram-negative bacteria but lacks real-world usage data concerning therapy types and patient demographics.
  • - A study of 200 cases found that cefiderocol was primarily used as targeted therapy (72.5%) rather than empirical (27.5%) and was administered equally as monotherapy (50.5%) and in combination (49.5%).
  • - The findings highlight that specific patient histories, like previous infections and conditions, influence the choice between monotherapy and combination therapy, emphasizing the need for better guidelines and further studies on treatment efficacy.
View Article and Find Full Text PDF

Objectives: Advancements in Artificial Intelligence(AI) have made platforms like ChatGPT increasingly relevant in medicine. This study assesses ChatGPT's utility in addressing bacterial infection-related questions and antibiogram-based clinical cases.

Methods: This study involved a collaborative effort involving infectious disease (ID) specialists and residents.

View Article and Find Full Text PDF

Objective: Binge eating is a mental health disorder related to weight gain, whose prevalence/correlation with weight excess in people with HIV (PWH) have been scarcely investigated.Design: A cross-sectional study of PWH who underwent the validated Binge Eating Scale (BES) questionnaire.

Methods: We included adult PWH during routine visits from October 2022 to February 2023.

View Article and Find Full Text PDF
Article Synopsis
  • Meropenem-vaborbactam is a new treatment option for infections caused by KPC-producing Klebsiella pneumoniae, particularly those resistant to ceftazidime-avibactam.
  • A study of 342 patients across 19 hospitals in Italy evaluated the outcomes of those treated with meropenem-vaborbactam, finding a 30-day mortality rate of 31.6%.
  • The research identified risk factors for higher mortality, including septic shock, significant comorbidities, and delayed treatment, while the administration of the drug within 48 hours of infection onset was linked to better outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Injectable cabotegravir/rilpivirine (ICAB/RPV) has recently become available for HIV treatment, and this study aimed to evaluate its impact on sleep disturbances in patients who switched to this therapy.
  • A total of 46 individuals participated, and they were assessed for sleep quality before and 12 weeks after starting ICAB/RPV using various sleep questionnaires; the demographic data and health records were also analyzed.
  • Results showed no significant changes in sleep disturbance scores, although 37% reported feeling their sleep quality improved, indicating that switching to ICAB/RPV might have minimal negative effects on sleep despite previous concerns.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiometabolic health is critical for women with HIV, prompting an analysis of how well they meet targets for hypertension, dyslipidemia, and diabetes in a specific cohort.
  • The study included 292 women, revealing that while a majority had a low cardiovascular risk, migrant women showed poorer outcomes in achieving hypertension and lipid targets compared to Italian women.
  • Findings suggest that current treatment approaches are inadequate, highlighting a need for stronger drug interventions, improved adherence to treatment, and lifestyle changes for better health outcomes, particularly for migrant women with HIV.
View Article and Find Full Text PDF

Background: Infections are one of the most common causes of death after lung transplant (LT). However, the benefit of 'targeted' prophylaxis in LT recipients pre-colonized by Gram-negative (GN) bacteria is still unclear.

Methods: All consecutive bilateral LT recipients admitted to the Intensive Care Unit of the University Hospital of Padua (February 2016-2023) were retrospectively screened.

View Article and Find Full Text PDF

Fungal infections (FIs) are one of the leading causes of morbidity and mortality within the first year of lung transplant (LT) in LT recipients (LTRs). Their prompt identification and treatment are crucial for a favorable LTR outcome. The objectives of our study were to assess (i) the FI incidence and colonization during the first year after a bilateral LT, (ii) the risk factors associated with FI and colonization, and (iii) the differences in fungal incidence according to the different prophylactic strategies.

View Article and Find Full Text PDF

Introduction: There are no randomized controlled trials to inform the choice of using adjunctive dexamethasone (AD) against Listeria monocytogenes meningitis (LMM) and data from observational studies are pretty conflicting.

Methodology: We performed a rapid review of the literature with quantitative analysis. A pairwise random-effects meta-analysis was implemented, pooling unadjusted and adjusted data.

View Article and Find Full Text PDF

People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.

View Article and Find Full Text PDF

Background: Women living with HIV (WLWH) are at increased risk of human papillomavirus (HPV)-related cancers. Throughout Europe, there is great heterogeneity among guidelines for screening programmes, access to HPV testing and HPV vaccination. The aim of this systematic review is to summarize available data on screening and prevention measures for HPV-related anogenital cancers in WLWH across the WHO European Region (WER).

View Article and Find Full Text PDF

Background: The introduction and evolution of antiretrovirals has changed the panorama of comorbidities in people living with HIV (PLWH) by reducing the risk of AIDS-defining cancers (ADC). By contrast, due to ageing and persistent inflammation, the prevalence and incidence of non-AIDS-defining cancers have significantly increased. Therefore, we aimed at describing cancer epidemiology in our cohort over 28 years.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous bacillary angiomatosis (cBA) is a rare vascular disorder primarily linked to Bartonella infections, typically seen in individuals with HIV, leading to potential underdiagnosis in those without severe immunosuppression.
  • A case of a 67-year-old Italian man with no major immunocompromising conditions illustrates the challenges of diagnosing cBA, as he experienced a lengthy symptom onset before proper identification.
  • Successful treatment involved a combination of antibiotics based on molecular testing, highlighting the need for clinicians to consider cBA in patients with milder immune issues and the importance of personalized treatment strategies due to the lack of established guidelines.
View Article and Find Full Text PDF

Objectives: How to detect the clinical impact of anticholinergic (AC) burden in people with HIV (PWH) remains poorly investigated. We cross-sectionally described the prevalence and type of AC signs/symptoms and the screening accuracy of three AC scales in detecting their presence in a modern cohort of PWH.

Methods: We calculated AC Burden Scale (ABS), AC Risk Score (ARS) and AC Drug Score (ADS) in 721 adult PWH and recorded the presence of AC signs/symptoms over the previous 3 months.

View Article and Find Full Text PDF

Even though SARS-CoV-2 was declared by WHO as constituting no longer a public health emergency, the development of effective treatments against SARS-CoV-2 infection remains a critical issue to prevent complications, particularly in fragile patients. The protease inhibitor nafamostat, currently used in Japan and Korea for pancreatitis, owing to its anticoagulant properties for disseminated intravascular coagulation (DIC), is appealing for the treatment of COVID-19 infection, because it potently inhibits the transmembrane protease serine 2 (TMPRSS2) that, after virus binding to ACE-2, allows virus entry into the cells and replication. Moreover, it could prevent the DIC and pulmonary embolism frequently associated with COVID-19 infection.

View Article and Find Full Text PDF